Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3
- 30 October 1998
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 282 (5390) , 946-949
- https://doi.org/10.1126/science.282.5390.946
Abstract
Vascular endothelial growth factor (VEGF) is a key regulator of blood vessel development in embryos and angiogenesis in adult tissues. Unlike VEGF, the related VEGF-C stimulates the growth of lymphatic vessels through its specific lymphatic endothelial receptor VEGFR-3. Here it is shown that targeted inactivation of the gene encoding VEGFR-3 resulted in defective blood vessel development in early mouse embryos. Vasculogenesis and angiogenesis occurred, but large vessels became abnormally organized with defective lumens, leading to fluid accumulation in the pericardial cavity and cardiovascular failure at embryonic day 9.5. Thus, VEGFR-3 has an essential role in the development of the embryonic cardiovascular system before the emergence of the lymphatic vessels.Keywords
This publication has 29 references indexed in Scilit:
- Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient MiceScience, 1997
- Endothelial apoptosis in Braf-deficient miceNature Genetics, 1997
- Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic MiceScience, 1997
- Mechanisms of angiogenesisNature, 1997
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Role of tissue factor in embryonic blood vessel developmentNature, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Mouse Mutants and Cardiac DevelopmentCirculation Research, 1996
- Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formationNature, 1995
- On the origin of the abdominal lymphatics in mammals from the vena cava and the renal veinsThe Anatomical Record, 1912